Sunflower Health Plan Sacroiliac Joint Interventions for Pain Management (PDF) Form
YesNoN/A
YesNoN/A
YesNoN/A
Treatment for sacroiliac joint (SIJ) dysfunction is usually conservative (non-surgical) and
focuses on trying to restore normal motion in the joint. In patients who have failed to respond to
conservative therapy, an SIJ injection can be helpful for both diagnostic and therapeutic
purposes. SIJ injections into the synovial sac of the SIJ may provide immediate and significant
pain relief.
Policy/Criteria
It is the policy of health plans affiliated with Centene Corporation® that invasive pain
management procedures performed by a physician are medically necessary when the relevant
criteria are met and the patient receives only one procedure per visit, with or without
radiographic guidance.
I. Sacroiliac joint injections are medically necessary for the following indications:
A. One diagnostic or therapeutic sacroiliac joint (SIJ) injection for SIJ pain, all of the
following:
1. Somatic or nonradicular low back and lower extremity pain below the level of L5
vertebra that interferes with activities of daily living (ADLs) for at least 3 months;
2. Tenderness by palpation present over SIJ;
3. There is a positive response to at least three SIJ pain provocation tests (distraction,
compression, thigh thrust, Gaenslen’s, Patrick’s test/FABER test, or sacral thrust);
4. The member/enrollee has failed to respond to conservative therapy including all of
the following:
a. ≥ 6 weeks chiropractic, physical therapy or prescribed home exercise program;
b. Nonsteroidal anti-inflammatory drugs (NSAIDs) ≥ 3 weeks or NSAIDs
contraindicated or not tolerated;
c. ≥ 6 weeks activity modification;
5. Clinical findings and imaging studies, when available, lack obvious evidence for disc-
related or facet joint pain;
6. No other possible diagnosis is more likely.
B. A second diagnostic or confirmatory sacroiliac joint injection when pain was improved
by at least 75% after the first diagnostic SIJ injection and at least 2 weeks have passed
since the initial injection.
C. Subsequent therapeutic SIJ injections for recurrence of pain, all of the following:
1. Initial therapeutic injection(s) led to ≥ 50% relief and functional improvement for at
least 2 months;
Page 1 of 8
CLINICAL POLICY
Sacroiliac Joint Interventions
2. Request is for SIJ administered for temporary relief of lower back pain in conjunction
with other noninvasive treatment methods (e.g., to participate in physical therapy),
and not as a stand-alone therapy;
3. SIJ injection is given at intervals at least 2 months apart;
4. Less than 4 therapeutic SIJ injections have been given at the same site in the last 12
months.
II. It is the policy of health plans affiliated with Centene Corporation that if pain does not
improve by ≥ 75% after the second diagnostic SIJ injection, subsequent SIJ injections are
not medically necessary because effectiveness has not been established.
III.It is the policy of health plans affiliated with Centene Corporation that continuation of
injections beyond 12 months is considered not medically necessary because
effectiveness and safety have not been established. When more definitive therapies
cannot be tolerated or provided, consideration will be made on a case by case basis.
IV. It is the policy of health plans affiliated with Centene Corporation that sacroiliac nerve
blocks are considered not medically necessary because effectiveness has not been
established.
V. It is the policy of health plans affiliated with Centene Corporation that radiofrequency
neurotomy (conventional, cooled, and pulsed) of the SIJ is considered not medically
necessary because effectiveness has not been established. High-quality studies are
lacking for conventional and pulsed radiofrequency neurotomy of the SIJ. For cooled
radiofrequency neurotomy, additional well-designed studies are needed to evaluate
effectiveness.
Background
Sacroiliac Joint Injections
Treatment for sacroiliac joint dysfunction is usually conservative (non-surgical) and focuses on
trying to restore normal motion in the joint. In patients who have failed 4 to 6 weeks of a
comprehensive exercise program, local icing, mobilization/manipulation and NSAIDs, an SIJ
injection can be helpful for both diagnostic and therapeutic purposes. SIJ injections into the
synovial sac of the SIJ may provide immediate and significant pain relief. Adding a steroid to the
solution injected may help to reduce any inflammation that may exist within the joint(s) and
result in a prolonged period of freedom from pain.8
A study by Visser et al. evaluated the effect of manual therapy and physiotherapy versus SIJ
injection for low back and leg pain using a single-blinded randomized trial of treatment for 51
patients with SIJ-related leg pain. The effect of the treatment was evaluated after 6 and 12 weeks.
Manual therapy had a significantly better success rate than physiotherapy (p = 0.003). The
authors concluded in the small single-blinded prospective study, manual therapy appeared to be
the choice of treatment for patients with SIJ-related leg pain.1 A second choice of treatment to be
considered is an intra-articular injection.1,22
Page 2 of 8
CLINICAL POLICY
Sacroiliac Joint Interventions
SIJ Radiofrequency Neurotomy
A growing number of studies have assessed the effect of treatment with radiofrequency
denervation on SIJ pain, with mixed results. Radiofrequency denervation, also known as RFA or
radiofrequency neurotomy, describes the use of radiofrequency energy to stop the transmission
of pain signals to the central nervous system.5 One study found no difference between
conventional radiofrequency ablation (RFA) and a sham treatment on pain relief.2 A 2017
publication of 3 randomized controlled trials of 681 participants with chronic low back pain
found no statistically significant improvement in pain from treatment with a standardized
exercise program plus RFA, versus the standardized exercise program alone.3 A systematic
review of 12 randomized controlled trials measuring the efficacy of radiofrequency neurotomy to
manage chronic low back pain showed moderate evidence for both short-term and long-term
improvement.23 Ho and colleagues noted that radiofrequency denervation of the sacroiliac joint
(SIJ) have been inconsistent because the variable sensory supply to the SIJ is difficult to disrupt
completely using conventional ablation. The authors concluded that denervation showed long-
term effectiveness for up to two years in the treatment of SIJ pain. However, there are limitations
of this study included with small sample size with a retrospective review with no placebo-control
or sham-control group.24 The American Society of Interventional Pain Physicians 2013
guidelines rate the evidence for cooled RFA as fair, and limited for conventional and pulsed
RFA.5 The North American Spine Society (NASS) guidelines indicate that consideration can be
given to cooled RFA of the sacral lateral branch nerves and dorsal ramus of L5 for patients with
sacroiliac joint pain diagnosed with dual diagnostic blocks. Additional randomized trials are
required to compare the various nerve ablation techniques of the lateral branch nerves for
sacroiliac joint pain.5,22
Coding Implications
This clinical policy references Current Procedural Terminology (CPT®). CPT® is a registered
trademark of the American Medical Association. All CPT codes and descriptions are copyrighted
2020, American Medical Association. All rights reserved. CPT codes and CPT descriptions are
from the current manuals and those included herein are not intended to be all-inclusive and are
included for informational purposes only. Codes referenced in this clinical policy are for
informational purposes only. Inclusion or exclusion of any codes does not guarantee coverage.
Providers should reference the most up-to-date sources of professional coding guidance prior to
the submission of claims for reimbursement of covered services.
CPT Code that supports coverage criteria
CPT®
Codes
27096
Injection procedure for sacroiliac joint, anesthetic/steroid, with image guidance
(fluoroscopy or CT) including arthrography when performed
CPT code that does not support coverage criteria
Page 3 of 8
CLINICAL POLICY
Sacroiliac Joint Interventions
CPT®
Codes
64451
64625
Injection(s), anesthetic agent(s) and/or steroid; nerves innervating the sacroiliac joint,
with image guidance (ie, fluoroscopy or computed tomography)
Radiofrequency ablation, nerves innervating the sacroiliac joint, with image guidance
(ie, fluoroscopy or computed tomography)
HCPCS code that supports coverage criteria
HCPCS
Codes
G0260
Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other
therapeutic agent, with or without arthrography
-
ICD-10-CM diagnosis codes that support coverage criteria
+ Indicates a code requiring an additional character
-
ICD 10 CM
Code
M43.08
M46.1
M47.818
Spondylolysis, sacral and sacrococcygeal region
Sacroiliitis, not elsewhere classified
Spondylosis without myelopathy or radiculopathy, sacral and sacrococcygeal
region
Sacrococcygeal disorders, not elsewhere classified
Other specified dorsopathies, lumbosacral region
Other specified dorsopathies, sacral and sacrococcygeal region
Sciatica
M53.3
M53.87
M53.88
M54.30 through
M54.32
M54.40 through
M54.42
M54.5
M54.89
M54.9
Lumbago with sciatica
Low back pain
Other dorsalgia
Dorsalgia, unspecified
Reviews, Revisions, and Approvals
Policy split from CP.MP.118 Injections for Pain Management. Minor
rewording for clarity. Clarified II. by adding “ ≥ 50%” to the statement.
Background updated.
Annual review of policy. Minor wording changes to match language in
other pain injection policies. References reviewed and updated, with
two additional references added. Specialty review completed.
Reworded II. for clarity.
Added New 2020 CPT code- 64625 as not medically necessary. Added
criteria stating SIJ nerve blocks as not medically necessary, along with
code 64451.
Revision
Date
08/18
Approval
Date
08/18
08/19
08/19
01/20
02/20
Page 4 of 8
CLINICAL POLICY
Sacroiliac Joint Interventions
Reviews, Revisions, and Approvals
Added Patrick’s test/FABER test as an acceptable pain provocation test
in I.A3. References reviewed and updated.
Updated I.A. to specify that the criteria applies to therapeutic injections
as well as diagnostic. Updated I.B. to state “A second diagnostic or
confirmatory sacroiliac joint injection when pain was improved by at
least 75% after the first diagnostic SIJ injection”, rather than that pain
did not improve. I.C. updated to specify “therapeutic” SIJ injection. II
was changed from 50% to 75%. Updated background. Replaced
member with member/enrollee in all instances. Changed “review date”
in the header to “date of last revision” and “date” in the revision log
header to “revision date.”
Annual review completed. References reviewed, updated, and
reformatted.
Annual review completed. Background updated with no impact to
criteria. References reviewed and updated. Specialist reviewed.
Revision
Date
07/20
Approval
Date
08/20
06/21
06/21
08/21
08/21
08/22
08/22